<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="pmed.1002735.t003" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pmed.1002735.t003</object-id>
 <label>Table 3</label>
 <caption>
  <title>Targets set in the UNGASS 2001 declaration of commitment on HIV/AIDS.</title>
 </caption>
 <alternatives>
  <graphic id="pmed.1002735.t003g" xlink:href="pmed.1002735.t003" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  <table frame="hsides" rules="groups">
   <colgroup span="1">
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
    <col align="left" valign="middle" span="1"/>
   </colgroup>
   <thead>
    <tr>
     <th align="left" rowspan="1" colspan="1">Global target set in 2001 Declaration</th>
     <th align="left" rowspan="1" colspan="1">Indicator (cited in 2006 report)</th>
     <th align="left" rowspan="1" colspan="1">Global result reported in 2006</th>
    </tr>
   </thead>
   <tbody>
    <tr>
     <td align="left" rowspan="1" colspan="1">Reduce by 2005 HIV prevalence among young men and women aged 15 to 24 in the most affected countries by 25% (Paragraph 47)</td>
     <td align="left" rowspan="1" colspan="1">Percentage of young men and women aged 15–24 who are infected with HIV</td>
     <td align="left" rowspan="1" colspan="1">Inconclusive (at the global level).
      <break/>2006 report gives global prevalence measures for this age cohort:
      <break/>‘Women: 4.1%
      <break/>(Measure of uncertainty: 3.2%–5.1%)
      <break/>Men: 1.6%
      <break/>(Measure of uncertainty: 1.2%–2.0%)’ but states,
      <break/>‘No comparable global data on this age cohort is available from
      <break/>2001. Progress towards target can only be measured in individual countries.’
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Ninety percent have access to information, education, and services to reduce their vulnerability to HIV infection (Paragraph 53)</td>
     <td align="left" rowspan="1" colspan="1">Percentage of youth aged 15–24 who correctly identify ways of preventing HIV transmission</td>
     <td align="left" rowspan="1" colspan="1">(Males) 33%
      <break/>(Country range: 7%–50% coverage)
      <break/>(Females) 20%
      <break/>(Country range: 8%–44% coverage)
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">By 2005, reduce the proportion of infants infected with HIV by 20% (Paragraph 54)</td>
     <td align="left" rowspan="1" colspan="1">Estimated percentage of infants born to mothers infected with HIV who are infected in 2005</td>
     <td align="left" rowspan="1" colspan="1">26% (in countries with generalised epidemics).
      <break/>‘There has been an estimated 10% reduction in HIV transmission between 2001 and 2005.’
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Eighty percent of pregnant women accessing antenatal care have information, counselling, and other HIV prevention services available to them, increasing the availability of and providing access for women and babies infected with HIV to effective treatment to reduce mother-to-child transmission of HIV (Paragraph 54)</td>
     <td align="left" rowspan="1" colspan="1">Percentage of HIV-positive pregnant women receiving ARV prophylaxis</td>
     <td align="left" rowspan="1" colspan="1">9%
      <break/>(Country range: 1%–59% coverage)
     </td>
    </tr>
    <tr>
     <td align="left" rowspan="1" colspan="1">Annual expenditure on the epidemic of between US$7 billion and US$10 billion in LMICs and countries experiencing, or at risk of experiencing, rapid expansion of HIV/AIDS (Paragraph 80)</td>
     <td align="left" rowspan="1" colspan="1">Total annual expenditure</td>
     <td align="left" rowspan="1" colspan="1">US$8,297,000,000
      <break/>Estimated range: $US7.4 billion–US$8.5 billion
     </td>
    </tr>
   </tbody>
  </table>
 </alternatives>
 <table-wrap-foot>
  <fn id="t003fn001">
   <p>Abbreviations: ARV, antiretroviral; LMIC, low- or middle-income country; UNGASS, UN General Assembly Special Session.</p>
  </fn>
 </table-wrap-foot>
</table-wrap>
